Are you Dr. Jones?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Roy Jones, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Colorado, and New York. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1976 - 1979
Duke University HospitalInternship, Internal Medicine, 1975 - 1976
Duke University School of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1980 - Present
TX State Medical License 2002 - 2024
CO State Medical License 1990 - 2003
NC State Medical License 1975 - 2002
MD State Medical License 1977 - 1980- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 128 citationsImpairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.Uday R. Popat, Rima M. Saliba, Rupinderjit S Thandi, Chitra Hosing, Muzaffar H. Qazilbash
Biology of Blood and Marrow Transplantation. 2009-06-01 - 26 citationsEx-vivo expansion of hematopoietic progenitor cells: Preliminary results in breast cancerIan K. McNiece, Roy B. Jones, Pablo J. Cagnoni, Scott I. Bearman, Yago Nieto
Hematology and Cell Therapy. 1999-04-01 - 19 citationsProphylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Ra...Simrit Parmar, Borje S. Andersson, Daniel R. Couriel, Mark F. Munsell, Marcelo Fernandez-Vina
Journal of Clinical Oncology. 2011-01-20
Grant Support
- Phase I Studies For Patients With Breast CancerNational Cancer Institute1994–1997
- Imaging/Treatment Of Advanced Breast Cancer With Yttrium 90 Bre3 RadiolabeledNational Center For Research Resources1996
- Imaging/Treatment Of Advanced Breast Cancer With Yttrium-90 Bre-3 RadiolabeledNational Center For Research Resources1994–1995
